Helen E Jo1,2, Ian N Glaspole3,4, Kovi C Levin3, Samuel R McCormack5, Annabelle M Mahar6, Wendy A Cooper7,6, Rhoda Cameron3, Samantha J Ellis8, Alice M Cottee9,7, Susanne E Webster9, Lauren K Troy9,7, Paul J Torzillo9,7, Peter Corte9, Karen M Symons3, Nicole Taylor9, Tamera J Corte9,7. 1. Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. helen.jo@sydney.edu.au. 2. Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia. helen.jo@sydney.edu.au. 3. Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia. 4. Faculty of Medicine, Monash University, Melbourne, Victoria, Australia. 5. Department of Radiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. 6. Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. 7. Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia. 8. Department of Radiology, The Alfred Hospital, Melbourne, Victoria, Australia. 9. Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Abstract
BACKGROUND AND OBJECTIVE: Multidisciplinary discussions (MDDs) have been shown to improve diagnostic accuracy in interstitial lung disease (ILD) diagnosis. However, their clinical impact on patient care has never been clearly demonstrated. We describe the effect that an ILD multidisciplinary service has upon the diagnosis and management of patients with suspected ILD. METHODS: Patients at two specialized centres with suspected ILD underwent ILD multidisciplinary team review (ILD-MDT) (standard ILD clinic visit and diagnostic review at ILD-MDD). We compared changes in ILD diagnosis and management at referral to those following the ILD-MDT. RESULTS: Ninety patients, 60% males (54/90), aged 67.3 years (SD = 11.4) were reviewed for suspected ILD. Overall, the ILD-MDT resulted in a change in specific ILD diagnosis in 48/90 (53%) patients. Of the 27 patients referred with a diagnosis of idiopathic pulmonary fibrosis (IPF), the diagnosis was changed at MDD in 10 patients. In contrast, seven patients had their diagnosis changed to IPF. There was also a significant reduction in 'unclassifiable' diseases and disease behaviour classifications provided additional information beyond ILD diagnosis. CONCLUSION: Dedicated tertiary ILD-MDT service has an important clinical impact on the care of the ILD patient, with frequent changes in ILD diagnosis and subsequent management. Further research to investigate long-term clinical outcomes of ILD-MDT is required.
BACKGROUND AND OBJECTIVE: Multidisciplinary discussions (MDDs) have been shown to improve diagnostic accuracy in interstitial lung disease (ILD) diagnosis. However, their clinical impact on patient care has never been clearly demonstrated. We describe the effect that an ILD multidisciplinary service has upon the diagnosis and management of patients with suspected ILD. METHODS:Patients at two specialized centres with suspected ILD underwent ILD multidisciplinary team review (ILD-MDT) (standard ILD clinic visit and diagnostic review at ILD-MDD). We compared changes in ILD diagnosis and management at referral to those following the ILD-MDT. RESULTS: Ninety patients, 60% males (54/90), aged 67.3 years (SD = 11.4) were reviewed for suspected ILD. Overall, the ILD-MDT resulted in a change in specific ILD diagnosis in 48/90 (53%) patients. Of the 27 patients referred with a diagnosis of idiopathic pulmonary fibrosis (IPF), the diagnosis was changed at MDD in 10 patients. In contrast, seven patients had their diagnosis changed to IPF. There was also a significant reduction in 'unclassifiable' diseases and disease behaviour classifications provided additional information beyond ILD diagnosis. CONCLUSION: Dedicated tertiary ILD-MDT service has an important clinical impact on the care of the ILD patient, with frequent changes in ILD diagnosis and subsequent management. Further research to investigate long-term clinical outcomes of ILD-MDT is required.
Authors: Traci N Adams; Chad A Newton; Kiran Batra; Muhanned Abu-Hijleh; Tyonn Barbera; Jose Torrealba; Craig S Glazer Journal: Lung Date: 2018-06-29 Impact factor: 2.584
Authors: Simon L F Walsh; Toby M Maher; Martin Kolb; Venerino Poletti; Richard Nusser; Luca Richeldi; Carlo Vancheri; Margaret L Wilsher; Katerina M Antoniou; Jüergen Behr; Elisabeth Bendstrup; Kevin Brown; Lucio Calandriello; Tamera J Corte; Vincent Cottin; Bruno Crestani; Kevin Flaherty; Ian Glaspole; Jan Grutters; Yoshikazu Inoue; Maria Kokosi; Yasuhiro Kondoh; Vasileios Kouranos; Michael Kreuter; Kerri Johannson; Eoin Judge; Brett Ley; George Margaritopoulos; Fernando J Martinez; Maria Molina-Molina; António Morais; Hilario Nunes; Ganesh Raghu; Christopher J Ryerson; Moises Selman; Paolo Spagnolo; Hiroyuki Taniguchi; Sara Tomassetti; Dominique Valeyre; Marlies Wijsenbeek; Wim Wuyts; David Hansell; Athol Wells Journal: Eur Respir J Date: 2017-08-31 Impact factor: 16.671
Authors: Federica Furini; Aldo Carnevale; Gian Luca Casoni; Giulio Guerrini; Lorenzo Cavagna; Marcello Govoni; Carlo Alberto Sciré Journal: Front Med (Lausanne) Date: 2019-10-31
Authors: Hiram Shaish; Firas S Ahmed; David Lederer; Belinda D'Souza; Paul Armenta; Mary Salvatore; Anjali Saqi; Sophia Huang; Sachin Jambawalikar; Simukayi Mutasa Journal: Ann Am Thorac Soc Date: 2021-01
Authors: Neal Dodia; Diana Amariei; Blaine Kenaa; Doug Corwin; Lydia Chelala; E James Britt; Ashutosh Sachdeva; Irina G Luzina; Jeffrey D Hasday; Nirav G Shah; Sergei P Atamas; Teri J Franks; Allen P Burke; Stella E Hines; Jeffrey R Galvin; Nevins W Todd Journal: Respir Med Date: 2021-02-11 Impact factor: 3.415